It all comes to the results of the GMP, if it is a great success then it opens all doors for studies not cancer related..
Non dilutive funding was mentioned many times by the Dr, the sporadic event kept them at bay, if a successful GMP will they return? Dx3 does not need ph 1 trials for people to start their own research but confirmation of our product can be made at scale is a must
It all comes to the results of the GMP, if it is a great success...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $1.229K | 175.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 3908415 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1144393 | 9 |
View Market Depth
| Last trade - 10.07am 17/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
